| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 01/21/2010 | WO2010006704A1 Oxazolopyrimidines as edg-1 receptor agonists |
| 01/21/2010 | WO2009134383A3 Vinyl substituted fatty acids |
| 01/21/2010 | WO2009120799A9 Methods of treating fibrotic disorders |
| 01/21/2010 | WO2009103319A3 Ezrin, serpin b5, peroxiredoxin-2 and heat shock protein beta-1 as autoantigens for treating or detecting streptococcal diseases |
| 01/21/2010 | US20100016557 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
| 01/21/2010 | US20100016440 Alpha-aminoamide derivatives useful as anti-inflammatory agents |
| 01/21/2010 | US20100016357 Use of Beta-Aminoalcohols for the Treatment of Inflammatory Disorders and Pain |
| 01/21/2010 | US20100016323 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors |
| 01/21/2010 | US20100016315 Iminopyridine Derivative and Use Thereof |
| 01/21/2010 | US20100016216 Adiponectin and uses thereof |
| 01/21/2010 | US20100015225 Solid dispersion of a neurokinin antagonist |
| 01/21/2010 | US20100015159 Compositions and methods for treating kidney disease |
| 01/21/2010 | US20100015149 Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases |
| 01/21/2010 | US20100015044 Methods and compositions for diagnosis of iga-and igm-mediated kidney diseases |
| 01/21/2010 | DE10004815B4 Menschliche intestinale Natriumphosphat-Kotransporter Human intestinal sodium phosphate cotransporter |
| 01/21/2010 | CA2730843A1 Oxazolopyrimidines as edg-1 receptor agonists |
| 01/21/2010 | CA2730281A1 Novel indole derivative having, carbamoyl group, ureido group and substituted oxy group |
| 01/21/2010 | CA2728095A1 Pyrazole-containing tricyclic compounds as antagonists of an ep1 receptor |
| 01/21/2010 | CA2727769A1 Novel compounds active as muscarinic receptor antagonists |
| 01/20/2010 | EP2145889A1 Fused heterocyclic derivative, pharmaceutical composition comprising the derivative, and use of the composition for medical purposes |
| 01/20/2010 | EP2145884A1 Indoledione derivative |
| 01/20/2010 | EP2145629A2 Use of neurotoxin therapy for treatment of urologic and related disorders |
| 01/20/2010 | EP2145621A1 Prevention of dehydration and reduction of gluconeogenetic losses of amino acids by means of propane-1,2,3-triol |
| 01/20/2010 | EP2144619A1 Novel uses of hibiscus, in particular pharmaceutical uses |
| 01/20/2010 | EP2144503A1 Hydroxymethyl ether hydroisoindoline tachykinin receptor antagonists |
| 01/20/2010 | EP1942914B1 Use of an activated zeolite as a pharmaceutical agent for reducing poisonous substances |
| 01/20/2010 | EP1648880B1 Therapeutic agents useful for treating pain |
| 01/20/2010 | EP1506214B1 6-11 bicyclic ketolide derivatives |
| 01/20/2010 | EP1456160B1 Vitamin d analogues |
| 01/20/2010 | EP1427396B1 Dosage forms having prolonged active ingredient release |
| 01/20/2010 | CN201384713Y Piperazine ferulate enteric-coated tablet |
| 01/20/2010 | CN101628905A C-aryl glucoside SGLT2 inhibitors and method |
| 01/20/2010 | CN100582774C Detection method of treating prostatitis formulation |
| 01/20/2010 | CN100582088C Aminoalcohol derivatives |
| 01/20/2010 | CN100581579C Medicinal composition for treating prostate disease and its preparation method and application |
| 01/20/2010 | CN100581572C Function of anemarrhena extract for preparing medicine of treating prostatic hyperplasia |
| 01/20/2010 | CN100581570C Traditional Chinese medicine decoction |
| 01/20/2010 | CN100581563C Method for preparing compound pyrrosia leaf capsule |
| 01/19/2010 | US7649095 Piperidine derivatives and agent comprising the derivative as active ingredient |
| 01/19/2010 | US7649001 Fused benzene derivative and use |
| 01/19/2010 | CA2537103C Once daily dosage forms of trospium |
| 01/19/2010 | CA2373255C Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria |
| 01/19/2010 | CA2239904C Inhibitors of interleukin-1.beta. converting enzyme |
| 01/14/2010 | WO2010006026A2 Improving renal function with quercetin-containing compositions |
| 01/14/2010 | WO2010004197A2 Pyridino-pyridinone derivatives, preparation thereof, and therapeutic use thereof |
| 01/14/2010 | WO2010004060A1 Use of cilastatin for reducing nephrotoxicity of different compounds |
| 01/14/2010 | WO2010003996A1 Eprosartan compositions |
| 01/14/2010 | WO2010003963A1 Use of opioid antagonists for treating urinary retention |
| 01/14/2010 | WO2009099650A4 Treatment of bladder diseases with a tlr7 activator |
| 01/14/2010 | US20100010055 Antagonists of the vanilloid receptor subtype 1 (vr1) and use thereof |
| 01/14/2010 | US20100010005 Renal Function with Quercetin-Containing Compositions |
| 01/14/2010 | US20100010004 Inhibitors of histone deacetylase |
| 01/14/2010 | US20100009988 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 01/14/2010 | US20100009972 Pyridyl Non-Aromatic Nitrogen-Containing Heterocyclic-1-Carboxylate Compound |
| 01/14/2010 | US20100009971 Pyridyl Non-Aromatic Nitrogen-Containing Heterocyclic-1-Carboxylate Compound |
| 01/14/2010 | US20100009945 3,2-dihydrofuran-1 alpha ,25-dihydroxy-19-nor-vitamin D3; prophylaxis of autoimmune diseases, some types of cancers, metabolic bone diseases, osteomalacia, osteopenia, secondary hyperparathyroidism, psoriasis, or other skin diseases; osteoporosis |
| 01/14/2010 | US20100009941 2-Methylene-20(21)-Dehydro-19-Nor-Vitamin D Analogs |
| 01/14/2010 | US20100009019 Processes for Extracting Phytochemicals from Pomegranate Solids and Compositions and Methods of Use Thereof |
| 01/14/2010 | US20100008913 Methods and compositions for treating platelet-related disorders |
| 01/14/2010 | US20100008859 Methods of treatment using ammonia-scavenging drugs |
| 01/14/2010 | CA2730211A1 Use of opioid antagonists for treating urinary retention |
| 01/14/2010 | CA2730065A1 Improving renal function with quercetin-containing compositions |
| 01/14/2010 | CA2730008A1 Eprosartan compositions |
| 01/14/2010 | CA2729833A1 Pyridino-pyridinone derivatives, preparation thereof, and therapeutic use thereof |
| 01/13/2010 | EP2143713A1 Novel pyrrolinone derivative and medicinal composition containing the same |
| 01/13/2010 | EP2143429A1 Use of cilastatin to reduce the nephrotoxicity of different compounds |
| 01/13/2010 | EP2142669A2 Sirtuin based methods and compositions for treating b- catenin-related conditions |
| 01/13/2010 | EP1144388B1 Acyl derivatives which treat vla-4 related disorders |
| 01/13/2010 | CN100579958C Racemized tamsulosin free alkali and preparation method thereof |
| 01/13/2010 | CN100579549C Medicinal composition for treating chronic nephritis and its preparing process |
| 01/13/2010 | CN100579522C Pasting agent |
| 01/12/2010 | US7645779 Linked biaryl compounds |
| 01/12/2010 | US7645774 Sulfonamide-containing benzene derivatives; cancer and inflammatory, immunomodulatory or respiratory diseases; allergy, seasonal allergic rhinitis, reversible airway obstruction, adult respiratory distress syndrome, asthma, or bronchitis |
| 01/12/2010 | US7645761 Indoline derivatives |
| 01/12/2010 | US7645754 Pyrrolopyrimidine A2B selective antagonist compounds, their synthesis and use |
| 01/12/2010 | CA2483678C 6-11 bicyclic ketolide derivatives |
| 01/12/2010 | CA2468412C 17.alpha.-alkyl-17.beta.-oxy-estratrienes and intermediates for their production, use of the 17.alpha.-alkyl-17.beta.-oxy-estratrienes for the production of pharmaceutical agents as well as pharmaceutical preparations |
| 01/12/2010 | CA2457351C Quinazolinone derivatives |
| 01/12/2010 | CA2438143C Modified proteins, designer toxins, and methods of making thereof |
| 01/12/2010 | CA2411418C Hydroxyformamidine derivatives and medicines containing the same |
| 01/12/2010 | CA2407838C Pyrano, piperidino, and thiopyrano compounds and methods of use |
| 01/12/2010 | CA2403514C 8-quinolinxanthine and 8-isoquinolinxanthine derivatives as pde 5 inhibitors |
| 01/12/2010 | CA2373281C Methods of treating diabetes using a complex of igf-1 and igfbp-3 |
| 01/12/2010 | CA2254954C Morphogen treatment for chronic renal failure |
| 01/07/2010 | WO2010002035A1 A therapeutic agent for a lower urinary tract disease and an agent for improving a lower urinary tract symptom |
| 01/07/2010 | WO2010001990A1 Tetracyclic compound |
| 01/07/2010 | WO2010001908A1 Anti-cd27 antibody |
| 01/07/2010 | WO2010001869A1 Tetra-substituted benzene compound and use thereof |
| 01/07/2010 | WO2010001485A1 Adsorbent for oral administration |
| 01/07/2010 | WO2010001185A1 Thieno [2,3-b] pyridine compounds with mglur activity |
| 01/07/2010 | WO2010001179A2 Calcium ion channel modulators & uses thereof |
| 01/07/2010 | WO2010000013A1 A sulfated polysaccharide compound and the preparation and use thereof |
| 01/07/2010 | US20100004254 Therapeutic agents useful for treating pain |
| 01/07/2010 | US20100004249 Bicyclic heterocyclic compound and use thereof |
| 01/07/2010 | CA2729688A1 Calcium ion channel modulators & uses thereof |
| 01/07/2010 | CA2729567A1 Anti-cd27 antibody |
| 01/07/2010 | CA2728301A1 Vinpocetine and eburnamonine derivatives for promoting bone growth |
| 01/07/2010 | CA2727698A1 A therapeutic agent for a lower urinary tract disease and an agent for improving a lower urinary tract symptom |
| 01/06/2010 | EP2141168A1 Heteroaryl derivatives |
| 01/06/2010 | EP2141147A1 Ornithine derivative |